全球In Silico藥物發現市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，In Silico藥物發現市場規模將從 2025 年的 42.1 億美元成長至 166.4 億美元，2026 年至 2034 年的複合年成長率為 16.51%。

隨著製藥公司積極採用計算方法來加速藥物研發進程，全球In Silico藥物發現市場正迅速發展。In Silico輔助藥物發現技術利用電腦模擬、人工智慧和先進演算法來識別潛在的候選藥物並預測其生物學行為。這種方法顯著降低了傳統實驗室藥物發現過程所需的時間和成本。

成長要素之一是對更快、更有效率的藥物研發的需求日益成長，尤其是在應對新興疾病和複雜病理方面。製藥和生物技術公司正在將人工智慧 (AI) 和機器學習融入藥物研發流程，以提高準確性和效率。此外，對生物資訊學和計算生物學投入的增加也進一步鞏固了市場地位。

隨著數位技術不斷變革藥物研發，In Silico藥物發現市場預計將持續成長。巨量資料分析和雲端運算在藥物發現領域的日益普及將提升預測建模能力。醫療保健產業正尋求創新解決方案以加速治療方法的研發，因此In Silico方法的應用有望顯著增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球In Silico藥物發現市場：按組成部分分類

• 市場分析、洞察與預測
• 軟體
• 服務

第5章：全球In Silico藥物發現市場：按應用領域分類

• 市場分析、洞察與預測
• 標靶分子的鑑定
• 目標檢驗
• 發現鉛
• 先導藥物最適化
• 臨床前試驗
• 其他

第6章：全球In Silico藥物發現市場：依最終使用者分類

• 市場分析、洞察與預測
• 製藥公司
• 生技公司
• 受託研究機構
• 學術研究機構
• 其他

第7章 全球In Silico藥物發現市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • SchrA¶Dinger Inc
  • Certara USA Inc
  • Charles River Laboratories International Inc
  • Evotec SE
  • BenevolentAI
  • Exscientia
  • Insilico Medicine
  • Atomwise Inc
  • Molecular Partners AG
  • Relay Therapeutics
  • XtalPi Inc
  • Numerate Inc

The In-Silico Drug Discovery Market size is expected to reach USD 16.64 Billion in 2034 from USD 4.21 Billion (2025) growing at a CAGR of 16.51% during 2026-2034.

The Global In-Silico Drug Discovery Market is rapidly gaining momentum as pharmaceutical companies increasingly adopt computational methods to accelerate drug development. In-silico technologies use computer simulations, artificial intelligence, and advanced algorithms to identify potential drug candidates and predict their biological behavior. This approach significantly reduces the time and cost associated with traditional laboratory-based drug discovery processes.

One of the major growth drivers is the rising demand for faster and more efficient drug development, particularly in response to emerging diseases and complex medical conditions. Pharmaceutical and biotechnology companies are integrating artificial intelligence and machine learning into drug discovery workflows to enhance accuracy and efficiency. Additionally, increasing investments in bioinformatics and computational biology are further strengthening the market.

Looking ahead, the in-silico drug discovery market is expected to expand as digital technologies continue to transform pharmaceutical research. The growing use of big data analytics and cloud computing in drug development will enhance predictive modeling capabilities. As the healthcare industry seeks innovative solutions to accelerate therapeutic discoveries, the adoption of in-silico methods is likely to increase significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Software
• Services

By Application

• Target Identification
• Target Validation
• Lead Discovery
• Lead Optimization
• Preclinical Testing
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

COMPANIES PROFILED

• Schrdinger Inc, Certara USA Inc, Charles River Laboratories International Inc, Evotec SE, BenevolentAI, Exscientia, Insilico Medicine, Atomwise Inc, Molecular Partners AG, Relay Therapeutics, XtalPi Inc, Numerate Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Target Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Target Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lead Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Lead Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Preclinical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IN-SILICO DRUG DISCOVERY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 SchrA¶Dinger Inc
  • 9.2.2 Certara USA Inc
  • 9.2.3 Charles River Laboratories International Inc
  • 9.2.4 Evotec SE
  • 9.2.5 BenevolentAI
  • 9.2.6 Exscientia
  • 9.2.7 Insilico Medicine
  • 9.2.8 Atomwise Inc
  • 9.2.9 Molecular Partners AG
  • 9.2.10 Relay Therapeutics
  • 9.2.11 XtalPi Inc
  • 9.2.12 Numerate Inc